The absence of maternal (e.g., CNS disorders), obstetric (e.g., diabetes, hypertension, placental insufficiency), or fetal (e.g., acute/chronic hypoxia) complications—conditions known to elevate S100β—may have influenced our results. This evidence concerns the gene S100B and central nervous system disorder.